Celgene (CELG) Updates on Multiple REVLIMID Trials in Treating NHLStreetInsider.com (subscription)The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidom…
Dostawa leków immunosupresyjnych.Puls BiznesuTACROLIMUS o przedłuzonym działaniu 0,001g 10 op 4. TACROLIMUS o przedłuzonym działaniu 0,003g 40 op 5. TACROLIMUS o przedłuzonym działaniu 0,005g 50 op 6. TACROLIMUS injekcje 5 op PAKIET 7 1. BASILIX…
Imprime PGG in Combination with Monoclonal Antibody Therapy Achieves 64 …PipelineReview.com (press release)EAGAN, MN, USA I December 10, 2012 I All subjects in a phase 1 study of high risk, chronic lymphocytic leukemia responded to the combination th…
Immunomedics Provides Clinical Updates on Subcutaneous Injections of …MarketWatch (press release)The complementarity-determining regions (CDRs) of veltuzumab are identical to rituximab, except for one amino acid residue, which appears to give veltuzu…
New Results add to Growing Body of Evidence That Support Bendamustine …PR Newswire UK (press release)Five sets of new data analyses presented this week at the 54th annual meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, show t…
HealioCombination of ibrutinib and rituximab shows promise against chronic …News-Medical.netA two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with min…
Roche announces positive studies of MabThera with subcutaneous injectionpharmabiz.comRoche has reported results from two studies which showed that a fixed dose of MabThera (rituximab) can be administered subcutaneously (SC), potentially allowing patien…
HealioDrug combination acts against aggressive chronic lymphocytic leukemiaOutcome Magazine (blog)12/10/2012 A two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound res…
ESME Think Tank Closing; Donations Go to ME Rituximab ProjectProHealthESME's website [http://esme-eu.com] will be accessible for approximately 1 year, but no new information will be added. The donations that were given to ESME will be given to a pr…
Trial of 5-Minute Subcutaneous Rituximab Injection: Positive ResultsProHealthDec 8: Basil, Switzerland-based Roche pharmaceuticals company reports positive results from two international phase III trials of its MabThera – a form of rituximab that can…